ERIK MCLEAN / UNSPLASH

Physikalisches Kolloquium

Freitag, 16. Oktober 2026 17:00 Uhr  Modern Nuclear Physics and the Study of Exotic Decays of Nuclei

Prof. Dr. Yury A Litvinov , GSI Helmholtz Center for Heavy Ion Research GmbH From Nuclei to Stars: β Decay of Highly Charged Ions Yury A. Litvinov GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany The famous phrase "we are all made of stardust" reflects a profound truth: nearly all visible matter in the Universe was forged in stellar interiors. Nucleosynthesis proceeds by nuclear fusion up to iron, beyond which nature relies on neutron capture and β-decay to build heavier elements. Yet our knowledge of β-decay rests almost entirely on studies of neutral atoms — a poor proxy for the interiors of stars, where atoms are stripped of most or all of their electrons. In this presentation we will show that decay properties can change dramatically for highly charged ions (HCI). Familiar radioactive decay channels can be blocked. New ones, unavailable to neutral atoms, can open up. These effects arise from the interplay between the electron shell and the nucleus, making them relevant to nuclear structure and stellar nucleosynthesis, as well as to atomic physics in its own right. Such measurements are carried out at the Experimental Storage Ring (ESR) at GSI, Darmstadt, presently the only facility dedicated to precision decay studies of HCIs, where freshly produced radionuclides are stored in ultra-high vacuum, preserving their high atomic charge state for extended periods.

Teilchenkolloquium

Particles for Health

Prof. Dr. Ulli Köster, Institut Laue-Langevin Particles for Health Ulli Köster Institut Laue-Langevin (ILL), Grenoble, France Various types of particles are essential ingredients for nuclear medicine applications. Nuclear medicine imaging procedures rely either on gamma-rays or on annihilation photons after positron annihilation, while charged particles with relatively short range are used for therapeutic applications. Targeted radionuclide therapies employing beta or alpha emitters have recently made tremendous progress in the treatment of metastasized cancers. Research is ongoing with Auger electron emitters that could ultimately provide still more precise targeting. While established radionuclides are commercially available, this is rarely the case for emerging radionuclides that are required for R&D towards novel radiopharmaceuticals. The PRISMAP+ collaboration has pooled European infrastructures to produce and distribute emerging radionuclides for medical research. Biomedical PRISMAP+ labs host external researchers to perform preclinical studies with emerging radionuclides. I will also present findings of an international working group that has analyzed historic publications on the discovery of Auger electrons. Funded by the European Union’s Horizon Europe research and innovation programme under grant agreement 101287718 (PRISMAP+).

Astronomisches Kolloquium

Dienstag, 20. Oktober 2026 16:30 Uhr  Again! - but faster, better, and with more physics: ML-accelerated inference of galaxy properties in deep and wide surveys of the universe

Joel Leja, Penn State University To arrange a visit with the speaker during the visit, please contact their host: Anna de Graaff

Zentrum für Quantendynamik Kolloquium

Mittwoch, 4. November 2026 16:30 Uhr  tba

Prof. Dr. Leticia Tarruell, ICFO – The Institute of Photonic Sciences, Spain